Recent Publications on : |  |
| Correlation of JAK2 V617F mutant allele quantitation with clinical presentation and type of chronic myeloproliferative neoplasm.
| 3rd November, 2009
| Clinical Pathology Department, William Beaumont Hospital, Royal Oak,
|
Hormonal control of luminescence from lantern shark (Etmopterus spinax) photophores.
The velvet belly lantern shark (Etmopterus spinax) emits a blue...
Direct Link | 3rd November, 2009
| Laboratory of Marine Biology, Catholic University of Louvain, B-1348
|
JAK2 Gets Histone H3 Rolling.
Activation of JAK2 is implicated in normal hematopoiesis as well as...
Direct Link | 3rd November, 2009
| Department of Medicine, Brigham and Women's Hospital and Harvard Medical
|
JAK2 V617F Mutation Detection: Laboratory Comparison of Two Kits Using RFLP and qPCR.
Aim: The JAK2 V617F mutation has been implicated in a variety of diseases...
Direct Link | 3rd November, 2009
| 1 Department of Pathology & Laboratory Medicine, American University of
|
Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells.
Adipositas correlates with an enhanced risk of developing malignant...
Direct Link | 31st October, 2009
| Junior Research Group, Paul-Ehrlich-Institute, Langen, Germany.
|
Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk.
OBJECTIVES:Genetic susceptibility is known to make a major contribution to...
Direct Link | 29th October, 2009
| [1] Department of Gastroenterology and Hepatology, University Medical
|
| [Treatment of myeloproliferative neoplasms except for chronic leukemia]
| 29th October, 2009
| Intractable Diseases Research Center, Tokyo Medical University.
|
| [Molecular mechanisms of myeloproliferative diseases and myelodysplastic syndromes]
| 29th October, 2009
| Department of Hematology and Oncology, Research Institute for Radiation
|
| [Classification of myeloid leukemias]
| 29th October, 2009
| Hematoimmunology, School of Health Science, Faculty of Medicine,
|
Deletion of tumor necrosis factor-alpha-receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis.
In diet-induced obesity, hypothalamic and systemic inflammatory factors...
Direct Link | 28th October, 2009
| Univesity of Campinas, Brazil;
|
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.
Constitutive activation of the EPO/JAK2 signaling cascade has recently...
Direct Link | 28th October, 2009
| Vertex Pharmaceuticals Inc., Cambridge, MA 02139-4242, United States.
|
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.
The design, synthesis and biological evaluation of a series of...
Direct Link | 28th October, 2009
| Department of Cancer Chemistry, AstraZeneca R&D Boston, 35 Gatehouse
|
Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes.
Chondrocytes are important for the development and maintenance of...
Direct Link | 27th October, 2009
| Department of Pharmacology, University Medical Center of the Johannes
|
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.
A common JAK2 germline haplotype (46/1) has been associated with JAK2V617F...
Direct Link | 23rd October, 2009
| Division of Hematology, Department of Medicine, Mayo Clinic, Rochester,
|
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.
The germline JAK2 haplotype 46/1, tagged by the 'C' allele of...
Direct Link | 23rd October, 2009
| Division of Hematology, Department of Internal Medicine, Mayo Clinic,
|
